Novo Nordisk expands site to manufacture GLP-1 drugs
The expansion comes as Novo is trying to maintain strong growth in type 2 diabetes (T2D) after the launch of Eli Lilly’s Zepbound this month.
27 November 2023
27 November 2023
The expansion comes as Novo is trying to maintain strong growth in type 2 diabetes (T2D) after the launch of Eli Lilly’s Zepbound this month.
People with eye infection symptoms should contact healthcare experts and inform them about the usage of recalled products.
The oral solution treats prophylaxis of organ rejection in patients with allogeneic transplants.
The treatment comprises intravenous doses of Sebelipase alfa administered every week in the at-home setting.
The Phase III NefIgArd clinical study assessed the safety and efficacy of Nefecon.
Gene therapy stands at the forefront of innovation, offering new possibilities for patients and a shift in the approach to treating this rare disease.
Epidiolex has been approved as an adjunct therapy for seizures associated with three rare forms of epilepsy in patients aged two years and older.
Bayer announced the launch of a manufacturing facility in Berlin, Germany, to meet future demands from the US, China and Europe.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.
Give your business an edge with our leading industry insights.